Skip to main content

Business Wire India

 

Clinical courses

  • Taro Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Keveyis™ (dichlorphenamide) 50 mg Tablets for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis.[1] Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.[2]

  • (Business Wire India) Wipro Limited, a leading global information technology, consulting, and business process services company, today announced that it has been selected by DSM, a global, science based company active in health, nutrition and materials, as its strategic IT partner to provide Workplace Services.

  • (Business Wire India); Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that it has delivered a strong consolidated financial performance for Q1 FY16.

  • (Business Wire India); Apollo Children’s Hospital has once again showcased its expertise and technical know-how on implementing some of the latest technologies for the benefit of patients. Surgeries performed at the Children’s Hospital using the da Vinci robot provides patients with all the advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.

  • OPTM Healthcare, with its ever evolving streak of innovating absolutely natural treatments with 100% recovery, has devised a remarkable alternative to treat osteoarthritis with phytomedicines. Its team of professional physicians has scientifically developed plant-originated Indian herbal medicines, known as phytomedicines, to use as an excellent cure for this disease along with many others.

  • The growth of the Indian metallic packaging industry is highly dependent on the progress made by the overall economy. With the country’s economy doing fairly well, the retail sector booming, and consumer awareness on the recycling and environmental benefits of tinplate packaging rising, the outlook for the industry looks positive.

  • (Business Wire India); Today, at the 2015 Commonwealth Health Ministers’ Meeting in Geneva, The Queen Elizabeth Diamond Jubilee Trust and partner Standard Chartered have unveiled an exclusive preview of Time to See, a landmark photography exhibition which captures the human impact of avoidable blindness in the Commonwealth, and the solutions readily available.

    • Time to See – multi-award winning photographers join forces to bring to world’s attention major causes of avoidable blindness
    • 80% of world’s blindness is avoidable. Exhibition Time to See shows human impact and work being delivered by The Queen Elizabeth Diamond Jubilee Trust, Standard Chartered and partners to end avoidable blindness.
  • (Business Wire India); Teva Pharmaceutical Industries Ltd. has announced that an updated investor presentation in connection with its proposed combination with Mylan N.V. is available on the Investor Relations section of the Company’s website and will be filed with the Securities and Exchange Commission (“SEC”).

Subscribe to Business Wire India